Q&A session with Drs. @LudaBazhenovaMD, Christina Baik, and @TejasPatilMD.

"How do you describe the 'quality of life' metric for targeted therapy?"

#LungCancer #EGFR #TP53 #RB1 #BRAF #NSCLC #SCLC #TargetedTherapies #LungCancerInformation

Do you want to learn more about #BRAF?

Join us now at our Lung Cancer Targeted Therapies OncTalk!

#LungCancer #TargetedTherapies #V600E #NSCLC #GRACE #LungCancerInformation

Now presenting Dr. Christina Baik:

"KRAS and BRAF mutated NSCLC".

#TargetedTherapies #LungCancer #GRACE #KRAS #NSCLC #BRAF

🧬 What does your molecular testing report really mean?

Join us March 21, 2026 for a live virtual lung cancer event led by Dr. Lyudmila Bazhenova.

Featuring Dr. Amanda Herrmann (UC San Diego Moores Cancer Center) presenting:
“Breaking Down a Molecular Testing Report.”

Register:
https://give.cancergrace.org/event/lung-cancer-targeted-therapies-onctalk-2026/e759491

Support free patient education — donate today. 💙

#LungCancer #NSCLC #TargetedTherapy

🎥 Now presenting Dr. Mara Antonoff: What Does “Oligometastatic” Lung Cancer Mean?

#LungCancer #LungCancerOncTalk2025 #LungCancerEducation #NSCLC

What local therapy options are out there?

Now presenting Dr. Jeff Ryckman, MD, MSMP, don't miss his amazing presentation and join us now!

https://lnkd.in/ebNvuu5J

#LungCancer #NSCLC #Radiotherapy #LocalTherapy #MetastaticLungCancer

Key Differences Between ESMO 2025 and Previous Recommendations for Early-Stage and Locally Advanced NSCLC

https://friendica.world/display/84b6ef2b-1068-b06f-86e8-dce342340841

Structured Summary of ESMO's Clinical Practice Guidelines for Early Stage and Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

https://friendica.world/display/84b6ef2b-1568-b062-21e5-f68402439453

Our amazing Brittany recording with Dr. Jinyong Kim (김진영) from Samsung Medical Center (삼성서울병원) in Korea.

She discussed updates on patients with NSCLC harboring EGFR mutations.

Stay tune for the complete Video Library coming soon!

#lungCancer #EGFR #NSCLC #Korean

First UK Lung Cancer Patient receives mRNA vaccine BNT116  
BNT116 and LungVax are nucleic acid lung cancer vaccine candidates – the former is based on mRNA technology similar to “COVID-19 mRNA vaccines” such...........
#BNT116 #Cancer #DNAVaccine #Lungcancer #LungVax #mRNAVaccine #nonsmallcelllungcancer #NSCLC #UK #Vaccine
Umesh Prasad

https://www.scientificeuropean.co.uk/medicine/first-uk-lung-cancer-patient-receives-mrna-vaccine-bnt116/